title: [The effect of integrin-linked kinase on VEGF expression in fibroblasts from human hypertrophic scar].
abstract: OBJECTIVE
  To explore the expression of integrin-linked kinase (ILK) and its effect on VEGF expression in fibroblasts from human hypertrophic scar.
  
  
  METHODS
  Fibroblasts were isolated from hypertrophic scar of 8 patients and cultured in vitro. Then the cells were divided into three groups: (1) Cells were cultured only in DMEM containing 10% FCS in the control group; (2) Cells were transfected with empty plasmid in the empty plasmid group; (3) Cells were transfected with plasmid expressing ILKcDNA in the ILK cDNA plasmid transfection group. First, the expression of ILK and VEGF was observed by immunocytochemistry before and after ILK cDNA transfection. Second, ILK and VEGF mRNA expression was investigated by real-time PCR (RT-PCR). Third, the protein expression of ILK and VEGF was detected by Western blot. Finally, the protein level of VEGF in supernatant of fibroblasts was measured by ELISA.
  
  
  RESULTS
  Before ILK cDNA transfection, the expression of ILK was positive and the VEGF expression was weak in cytoplasm of fibroblasts . After ILK cDNA transfection, both the expression of ILK and VEGF was enhanced. The level of VEGF mRNA was significantly higher in ILK cDNA transfection group (0.338 +/- 0.060) than that in control group (0.022 +/- 0.001) and empty plasmid group (0.028 +/- 0.005, P < 0.05). The level of VEGF protein was significantly higher in ILK cDNA transfection group (0.819 +/- 0.019) than that in control group (0.607 +/- 0.033) and empty plasmid group (0. 591 +/- 0.024, P<0. 05). Secretion of VEGF increased remarkably in ILK cDNA transfection group comparing with the other two groups (P < 0.05).
  
  
  CONCLUSIONS
  ILK could up-regulate the VEGF mRNA and protein level in human scar fibroblasts. It may play an important role in the angiogenesis in hypertrophic scar.
authors.affiliation: Department of Burns and Plastic Surgery, Guangzhou Red Cross Hospital, Jinan University Medical College, Guangzhou 510220, China.
authors.forename: Lan
authors.initials: L
authors.lastname: Mi
authors.forename: Ye-yang
authors.initials: YY
authors.lastname: Li
authors.forename: Wei-hua
authors.initials: WH
authors.lastname: Lin
authors.forename: Gang
authors.initials: G
authors.lastname: Li
authors.forename: Jing-en
authors.initials: JE
authors.lastname: Sun
authors.forename: Li-bing
authors.initials: LB
authors.lastname: Dai
authors.forename: Reng-kun
authors.initials: RK
authors.lastname: Wang
mesh_terms: D002478:Cells, Cultured; D017439:Cicatrix, Hypertrophic / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D005347:Fibroblasts / Q000378:metabolism*; D006801:Humans; D010957:Plasmids; D017346:Protein Serine-Threonine Kinases / Q000235:genetics*; D012333:RNA, Messenger / Q000235:genetics; D014162:Transfection; D042461:Vascular Endothelial Growth Factor A / Q000378:metabolism*; D000099200:Scaffold Protein ILK
chemical_list: D017346:Protein Serine-Threonine Kinases; D012333:RNA, Messenger; D042461:Vascular Endothelial Growth Factor A; D000099200:Scaffold Protein ILK; C467484:VEGFA protein, human